Their findings elucidated the pivotal role of TLR2 activation by infectious bacterial peptidoglycan (PGN) in bolstering breast cancer cell invasiveness (48), unveiling a novel link between infectious bacteria and cancer cells with potential therapeutic implications for antibiotic intervention in cancer treatment. This evidence concerns the gene TLR2 and breast carcinoma.